Caffeine and Sodium Benzoate
CAFFEINE AND SODIUM BENZOATE INJECTION, USP
Approved
Approval ID
b2c6b352-f837-4903-8e4c-fb0a2b20bb60
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 6, 2019
Manufacturers
FDA
American Regent, Inc.
DUNS: 002033710
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Caffeine and Sodium Benzoate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0517-2502
Product Classification
G
Generic Name
Caffeine and Sodium Benzoate
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateDecember 6, 2019
FDA Product Classification
INGREDIENTS (5)
SODIUM BENZOATEInactive
Quantity: 125 mg in 1 mL
Code: OJ245FE5EU
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CAFFEINEActive
Quantity: 125 mg in 1 mL
Code: 3G6A5W338E
Classification: ACTIB
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT